OPAL: "Opiates and PhArmacoLogy"

计划入组 263 人 · 首次发布于 2013 年 5 月 7 日

Neuroimaging of Opioid Phase (OPAL)

计划入组 140 人 · 首次发布于 2023 年 6 月 15 日

The Opal - COVID-19 Study

计划入组 50 人 · 首次发布于 2021 年 7 月 27 日

Opal

Opal-I

OPAL-0012

Opal Rheumatology Ltd.

Black Diamond Therapeutics

United States

BLACK DOG INSTITUTE

Australia

Ansa Biotechnologies Raises $54.4 Million Series B to Revolutionize DNA Synthesis with Enzymatic Platform

Ten63 Therapeutics Raises $45M to Advance AI-Driven Drug Discovery Platform Targeting Previously Undruggable Proteins

Clario Partners with Oxford to Advance Parkinson's Disease Research Using Opal Wearable Sensors